Anson Funds Management LP 13D and 13G filings for TransCode Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 9:55 pm Purchase | 2025-06-30 | 13G | TransCode Therapeutics, Inc. RNAZ | Anson Funds Management LP | 27,125 0.100% | 23,072 (+569.29%) | Filing |
| 2025-02-14 5:16 pm Purchase | 2024-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | Anson Funds Management LP | 4,053 9.900% | 4,053 (New Position) | Filing |